Preserving and enhancing the primary function of transplanted islets is not only crucial for improving the outcome of the islet transplantation, but is also important for reducing the islet mass required to achieve insulin independence. Uncoupling protein 2 (UCP2) is a member of the uncoupling protein family, which is localized to the inner mitochondrial membrane and negatively regulates insulin secretion in the pancreatic β-cells. In this study, we assessed the importance of UCP2 in improving islet graft primary function by using UCP2 gene-knockout (UCP2-KO) mice in a syngeneic islet transplantation model. Islets were isolated from UCP2-KO or wild-type (WT) C57BL/6J mice. The effects of deficiency of UCP2 on islet transplantation and islet function were determined. Two hundred islets from UCP2-KO, but not from WT, donors were capable of completely restoring normoglycemia in 1 week in all syngeneic diabetic recipients. Islets harvested from UCP2-KO mice secreted onefold more insulin in GSIS assay than that from WT mice, and maintained normal GSIS after 72-h exposure to high glucose challenge. In addition, UCP2-KO islets expressed twohold higher Bcl-2 mRNA than that from WT islets, and were resistant to high glucose and proinflammatory cytokine induced death. Our study explored a potential mechanism that may explain the benefit of UCP2-KO islets in islet transplantation. Targeting UCP2 may provide a novel strategy to improve primary function of transplanted islets and reduce the number of islets required in transplantation.
INTRODUCTION
Transplanted islets are particularly vulnerable in the immediate posttransplantation period (7). Recent study indicated recipient hyperglycemia rendered islet grafts Diabetes mellitus is now fast emerging as one of the biggest health catastrophes in modern society. It was essusceptible to dysfunction and failure. An increased incidence of primary nonfunction was observed when a timated that approximately 160 million people worldwide suffered from diabetes in 2000, and this number marginal number of islets were transplanted into severely diabetic mice, in comparison with moderately diwas projected to increase to 221 million in 2010 and to 366 million in 2030 (25) . abetic mice (12). Hyperglycemia increased oxidative stress and deteriorated β-cell function in transplanted isRecent progress in the pancreas' enzymatic digestion process along with novel immunosuppression strategies lets. Islet graft response to transplantation injury includes upregulation of protective as well as apoptotic has led to successful clinical trials of islet transplantation in humans (18). However, successful islet transplangenes (17) . Therefore, preserving and enhancing the primary function of transplanted islets are not only crucial tation depends on the infusion of higher mean islet mass (>10,000 IE/kg) prepared from 2-4 donor pancreases to for improving the outcome of the islet transplantation, but also important for reducing the islet mass required to achieve insulin independence; the scarcity of islets donors severely limits the number of transplants that can achieve insulin independence, especially in the current limited sources of islets. be performed in diabetic subjects because only a small fraction of implanted islets can survive and become enUncoupling protein 2 (UCP2) is a member of the uncoupling protein (UCP) family, which is localized to the grafted (19) . inner mitochondrial membrane; it is the only known unIslet Transplantation and Graft Function Evaluation coupling protein expressed in pancreatic β-cells to date
Islet transplantation was performed as previously de-(4). Activated UCP2 may compete with ATP syntheses scribed (24). Briefly, the WT recipients were anesthefor the electrochemical energy of mitochondria and retized with 100 mg/kg ketamine and 10 mg/kg xylazine. sult in decreased cellular ATP/ADP levels. Consequently, Under sterile conditions, the kidney was externalized UCP2 negatively regulates pancreatic β-cell insulin sethrough a small incision in the flank. A total of 300 or cretion (22). Increasing experiment evidence suggests 200 fleshly isolated islets of similar size (ϳ150 µm in that the impairment of glucose-stimulated insulin secrediameter) from UCP2-KO or WT donors were aspirated tion (GSIS) plays an important pathophysiological role into PE50 tubing, and then inserted under the renal capin the development of β-cell dysfunction. It has been sule. Islet graft function was monitored by serial blood shown that downregulation of UCP2 improves GSIS unglucose measurements through tail vein bleeding from der pathophysiologyical conditions (9,11,12). Taken tofasting mice (Accu-Check III blood glucose monitor, gether, these findings suggest that pancreatic β-cell Biehringer Mannheim, Idianapolis, IN). Primary graft UCP2 is a potential target for improving islets function. nonfunction was defined as the inability to reach nonfasTo date, the role of UCP2 on mitochondrial ATP proting blood glucose levels less than 200 mg/dl for two duction and β-cell insulin secretion has been studied in consecutive measurements 5 days posttransplantation (13). type 2 diabetes mouse models (6,22). In the present Glucose Tolerance Test (GTT) study, we assessed the importance of UCP2 in improving islet graft primary function by using UCP2 geneMice were fasted overnight and injected intraperitoknockout mice in a syngeneic islet transplantation model. neally with glucose solution at a dose of 1 g/kg body weight. Blood glucose levels were measured before and MATERIALS AND METHODS at 10-min intervals after glucose injection.
Experimental Animals
Islets Glucose-Stimulated Insulin Secretion (GSIS) UCP2 gene knock-out (UCP2-KO, C57BL/6J) and After being isolated as above, islets were incubated in UCP2 wild-type (WT, C57BL/6J) mice were provided RPMI-1640 containing 11 mM glucose (normoglycemia by Dr. Bradford B. Lowell (Beth Israel Deaconess Medcondition) or RPMI-1640 containing 25 mM glucose ical Center, Boston, MA). All mice were raised and (hyperglycemia condition). The procedure was followed maintained in the animal facilities of University of Pittsas previously described (21) with some modifications. burgh. Mice at 8-10 weeks of age and with body weight Before assay, groups of 10 islets of similar size were around 25 g were used in the experiment. All animal transferred to microcentrifuge tubes, pelleted, and the protocols are approved by the Institutional Animal Care medium aspirated and preincubated in Krebs-Ringer's and Usage Committee at the University of Pittsburgh.
Buffer (KRB) with 3 mM glucose for 1 h at 37°C. After Islet Isolation and Culture washing, they were incubated in fresh KRB containing either low glucose (3 mM) or high glucose (20 mM) for The islet isolation of UCP2-KO and WT C57BL/6J 30 min. Supernatant from each well was collected after mice was conducted in parallel as described previously each 30 min incubation (first 3 mM and then change to (24). Briefly, the pancreas was injected through the pan-20 mM), and the concentration of insulin was measured creatic duct with Hanks' buffered saline solution (HBSS, using rat/mouse insulin ELISA kit (Linco Res.Inc). InMediatech, Herndon, VA) containing collagenase type sulin secretion was expressed as percentage of insulin V (Sigma, St. Louis, MO), excised, digested for 10-15 content. Islet DNA was measured using the CyQUANT min at 37°C water bath, and then filtered through a 500-cell proliferation assay kit (Molecular Probes). µm wire mesh. The digested pancreas was rinsed with HBSS, and islets were separated by Ficoll gradient cen-
Assessment of Islet Cell Viability by Confocal trifugation. After several washes in HBSS, islets were
Imaging Analysis handpicked and maintained in RPMI-1640 (Mdeiatech)
The viability of islets was determined by a semiquancontaining 11 mM glucose.
titative measurement using propidium iodide (PI) stainStreptozocin (STZ) Treatment ing, a vital dye that only permeates cells with damaged membranes. The percentage of dead cells in the islets is Eight-to 10-week-old male WT C57BL/6J mice with body weight around 25 g were used as islet graft recipiapproximated by visual enumeration (1). Isolated islets were exposed to the 25 mM high glucose and three inents that were rendered diabetic with a single intraperitoneal injection (250 mg/kg) of STZ (Sigma). An animal flammatory cytokines IL-1β (5 ng/ml), IFN-γ (100 ng/ ml), and TNF-α (10 ng/ml) for 24 h (all from Roche was considered diabetic after two consecutive blood glucose readings >300 mg/dl. Diagnostics). Then the islets were double stained with PI and Hoechst 33342 nuclear dyes (Sigma) before imaging analysis using confocal fluorescent microscope.
Quantification of Gene Expression
For real-time RT-PCR analysis, total RNA was extracted from whole islets and recovered islet grafts using RNeasy Plus Mini (Qiagen). First-strand cDNA was synthesized from total RNA by RT reaction using SuperScript First-Strand Synthesis SuperMix (Invitrogen). The quantitative real-time PCR analysis was performed on Real-time-PCR system 7500 (Applied Biosystems, Foster City, CA) using the Assay-onDemand TaqMan probes (Mm00627598_m1 for UCP2, Mm00477631_m1for Bcl-2, all from Applied Biosystems).
Statistical Analyses
Statistical analyses were performed using a two-tailed Student's t-test and two-way ANOVA with Bonferroni post hoc test. A value of p < 0.05 was considered significant.
RESULTS

UCP2 Deficiency Improves Primary Function of Pancreatic Islet Grafts
To determine the effects of UCP2 deficiency on primary function of islet grafts we utilized a syngeneic islet transplantation model. The C57BL/6J recipients were rendered diabetic by single injection of STZ and were randomly assigned to two groups. Because our preliminary data showed that 300 islets from both UCP2-KO and WT C57BL/6J donors were capable of restoring the normal glycemia on day 3 posttransplantation in all diabetic syngeneic WT recipients (Fig. 1A) , we utilized 200 islets in this study to assess islet function after transplantation into syngeneic recipients. Aliquots of 200 freshly isolated islets of similar size (ϳ150 µm in diameter) from UCP2-KO or WT donors were transplanted under the renal capsule of diabetic recipients (478 ± 10.2 mg/ dl). As show in Figure 1B , diabetic mice transplanted with 200 islets from UCP2-KO mice were completely restored to normoglycemia (146.8 ± 5.1mg/dl) in 1 week. formed at day 12 posttransplantation (Fig. 1C) . Follow-UCP2-KO versus WT: *p < 0.05 and **p < 0.01; unpaired, two-tailed Student's t-test.
ing intraperitoneal infusion of glucose (1 g glucose/kg mouse weight), the recipients receiving UCP2-KO islets atic islets were isolated from UCP2-KO and wild-type control mice, cultured 24 or 72 h in 11 mM glucose, and exhibited normal glucose profiles. After 20 min of glucose load, blood glucose levels were elevated to 519.2 ± then assessed GSIS. As shown in Figure 3A and B, UCP-KO islets secreted 1.5-fold higher insulin under 29.2 mg/dl, followed by a decline to prechallenge levels within 2 h. In contrast, the elevated glucose levels of high glucose stimulation than that from WT mice (1.86 ± 0.2% vs. 0.80 ± 0.2% of insulin content, respectively, recipients receiving WT islets followed glucose load declined slowly and remained at 245.0 ± 25.1 mg/dl upon after 24-h culture; p < 0.001). These data are consistent with other reports showing that UCP2 deficientcy en-2-h post-glucose challenge, a impaired pattern of GTT (Fig. 1C) . Area under the curve (AUC) is 33,100 versus hanced the islets' GSIS (9,22). The insulin content was normalized with DNA content (Table 1) . 43,257.
UCP2 Gene Expression Is Increased by Glucose The Islets From UCP2-KO Mice Are More Challenge In Vitro Potent After Exposed to High Glucose Challenge Both in Short Term and Long Term
To assess the effect of high glucose on UCP2 gene expression in islets, we performed real-time quantity
Studies have shown that chronically elevated glucose PCR. As expected, no UCP2 mRNA expression was delevels can cause β-cell dysfunction (11). The transtected from UCP2-KO islets. The UCP2 mRNA levels planted islets exposed to sustained hyperglycemia in diafrom WT islets that were exposed to 25 mM glucose for betic recipients have shown impaired β-cell function 72 h was significantly increased 2.3-fold in comparison (10). Then, we further tested whether UCP2-KO islets with base level expression (p < 0.05) (Fig. 2) . This is were more resistant to hyperglycemia-induced GSIS imconsistent with previous reports that both UCP2 protein pairment. We incubated WT and UCP2-KO islets in levels and mRNA were upregulated by hyperglycemia RPMI-1640 medium containing 25 mM glucose for 24 (11,15).
and 72 h and then assessed GSIS (Fig. 3C, D) . Following high glucose culture, islets increased basal insulin UCP2-KO Pancreatic Islets Have Increased release in both groups in a time-dependent manner. WT Insulin Secretion islets had elevated basal insulin secretion from 0.04% to Previous studies indicated that UCP2 negatively reg-0.25% after 24-h culture (p < 0.001) and further elevaulates insulin secretion. We investigated the direct effect tion to 0.63% after 72-h chronic culture (p < 0.001). of UCP2 deficiency on islets' insulin secretion. Pancre-UCP2-KO islets had elevated basal insulin secretion from 0.05% to 0.4% after 24-h culture (p < 0.001) and further elevation to 0.80% after 72-h chronic culture (p < 0.001). Although after 24-h exposure to 25 mM high glucose condition, both WT and UCP2-KO islets maintained normal GSIS to a subsequent high glucose challenge, the UCP2-KO islets secreted significantly more insulin than that from WT islets (p < 0.001) (Fig.  3B) . Interestingly, while the GSIS function of WT islets was significantly impaired after 72-h exposure to 25 mM high glucose condition (p > 0.1) (Fig. 3C) , the GSIS function of UCP2-KO islets remained intact and maintained the ability to secrete insulin in response to a subsequent high glucose challenge (p < 0.005) (Fig.  3C ). The insulin content was normalized with DNA content (Table 1) . To explore the underlying mechanism of UCP2 defipression in WT islets. UCP2 mRNA expression levels in WT islets cultured for 72 h at 25 mM high glucose were measured.
UCP2-KO Islets Were Resistant to High Glucose and Proinflammatory Cytokine-Induced Death
ciency to mediate improvement of islet graft function, Expression levels are expressed as relative to the control group we studied the effect of UCP2 on islet viability and (before culture). Results are expressed as mean ± SEM from function in response to an adverse environment of hythree independent repeats with six replicates. UCP2 gene relaperglycemia and proinflammation, which mimics the tive to an arbitrary value of 1, which was assigned to the exposttransplantation circumstance. We incubated freshly pression levels in control animals. *p < 0.05, unpaired, twotailed Student's t-test.
isolated islets (n = 50) for 24 h in the absence or pres- Figure 3 . UCP2-KO islets had increased insulin secretion in response to the stimulation of high glucose and are more potent after exposed to high glucose challenge both in short term and long term. (A) Islets isolated from the knock-out (UCP2-KO) or wildtype (WT) mice were incubated with 11 mM glucose in RPMI-1640 medium for 24 h. After washing, islets were exposed to 3 mM glucose in Krebs-Ringer's Buffer and then 20 mM glucose in Krebs-Ringer's Buffer for 30 min each. Insulin secretion in response to varying glucose was measured (GSIS). (B) Islets were exposed to 25 mM glucose in RPMI-1640 medium for 24 h and washed, then GSIS was performed. (C) Islets were exposed to 25 mM glucose in RPMI-1640 medium for 72 h and washed, then GSIS was performed. (D) Islets were exposed to 11 mM glucose in RPMI-1640 medium for 72 h and washed, then GSIS was performed. Results are expressed as mean ± SEM from three independent repeats with each condition carried out in six replicates and 10 islets in each replicate. The results were normalized to total insulin content and the number of islets present. **p < 0.001 UCP2 versus WT; #p < 0.05 and ##p < 0.001 25 mM versus 3mM; NS: no significant difference; two-way ANOVA with Bonferroni posttests. UCP-KO 6.2 ± 1.5 7.3 ± 0.8 6.7 ± 0.9 8.9 ± 1.7 WT 6.4 ± 2.0 8.1 ± 1.1 6.6 ± 1.8 9.2 ± 1.5
This table was used to calculate the GSIS data present in Figure 3 . Before islets culture, insulin content relative to DNA content was similar in UCP2-KO versus control wild-type (WT) (data not shown). High glucose (25 mM) incubation increased both insulin and DNA content in islets from UCP-KO and WT mice in a timedependent manner, but insulin content relative to DNA content was unchanged.
ence of 25 mM high glucose and a mixture of IL-1β, in 3 days when transplanted into syngeneic streptozotocin-induced diabetic recipients (Fig. 1A) . To examine IFN-γ, and TNF-α at the concentrations typically applied in previously published studies (21). Before confothe potency of UCP2-KO islets, we transplanted a suboptimal mass of 200 islets from either WT or UCP2-KO cal imaging analysis, double nuclear staining was applied using PI and Hoechst 33342 (for staining all the donors. When 200 islets from WT donors were transplanted into syngeneic diabetic recipients, they were unnuclei). As Figure 4 shows, approximately 50% of the islets from wild-type donors were PI staining positive, able to reverse hyperglycemia until up to 22 days posttransplantation (Fig. 1) . Our study corroborates a recent indicating they were nonviable. In contrast, only 28.1 ± 1.6% UCP2-KO islets were PI staining positive (p < reported that hyperglycemia correlated with the likelihood of primary nonfunction of marginal islet mass 0.001), suggesting that the UCP2-deficient islets were resistant to high glucose and proinflammatory cytokinetransplantation in rodent models (12, 14) . In contrast, 200 islets from UCP2-KO donors were able to rapidly induced death.
To further explore the mechanism, we determined the normalize glucose levels in 1 week in all diabetic syngeneic WT recipients (Fig. 1B) . These data indicated that mRNA expression levels of Bcl-2, a gene associated with cell survival (5), from UCP2-KO and WT islets, UCP2-KO islets were more potent in reversing hyperglycemia in syngeneic diabetic recipients. The results of consistent with a previous report that the Bcl-2 is expressed at low levels from freshly isolated WT islets glucose tolerance test conducted on posttransplantation day 12 supported this conclusion. As elucidated in Fig-(20) . However, after exposure to high glucose culture, UCP2-KO islets expressed twofold higher Bcl-2 mRNA ure 1B, the recipients receiving UCP2-KO islets exhibited normal glucose profiles following intraperitoneal levels in comparison with that from WT islets, which correlated with the resistance of UCP2-KO islets to the infusion of glucose. The blood glucose levels were elevated to peak levels followed by a decline to prechaldeleterious effects of high glucose challenge. lenge levels within 2 h (Fig. 1C) . In contrast, the recipi-DISCUSSION ents receiving WT islets demonstrated an impaired pattern of GTT; the elevated glucose levels following β-Cells sense glucose through its metabolism, resulting in increasing ATP, which closes K ATP channels leadglucose load decline slowly and remained at 245.0 ± 25.1 mg/dl upon 2 h post-glucose challenge (Fig. 1C ). ing to a depolarization of the cell membrane potential, increases Ca 2+ influx, and finally stimulation of insulin In transplanted islets, the deleterious effects of hyperglycemia on β-cell function have been described in mice secretion. UCP2 mediates mitochondrial proton leak, decreasing ATP production, and decreasing ATP/ADP raand humans (8,10,14). Impairment of GSIS plays an important pathophysiological role in the development of β-tio. Our previous study established that UCP2 negatively regulates GSIS (20). In the present study, we sought to cell dysfunction. Indeed, our results showed that islets cultured in high glucose medium were associated with examine the effects of UCP2 in the contest of syngeneic islet transplantation.
markedly increased UCP2 mRNA expression levels (Fig.  2) . Moreover, the increased UCP2 mRNA expression in Studies have showed that an adequate mass of islets is critical to achieve primary islet graft function both in WT islets correlated with severely impaired GSIS and lost glucose sensing after chronic high glucose challenge human and animal models (12). In our experimental setting, 300 islets isolated from both WT and UCP2-KO (Fig. 3B, C) . In contrast, UCP2-deficient islets enhanced the islet GSIS and maintained the ability to increase in-C57BL/6 donors were capable to reverse hyperglycemia Bcl-2 mRNA expression levels in islets cultured for 72 h at 25 mM high glucose were measured. Expression levels are expressed as relative to the WT group. White bar: group UCP2-WT; black bar: group UCP2-KO. Results are expressed as mean ± SEM from three independent repeats with six replicates. Bcl-2 gene relative to an arbitrary value of 1, which was assigned to the expression levels in WT. **p < 0.001 versus WT, unpaired, two-tailed Student's t-test. Scale bar: 100 µM.
